Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2007-01-16
2007-01-16
Wax, Robert A. (Department: 1653)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S252300, C435S254110, C435S320100, C435S325000, C530S363000, C536S023400
Reexamination Certificate
active
10888887
ABSTRACT:
The present invention provides a human serum albumin-TIMP2 fusion protein having the amino acid sequence set forth in SEQ ID NO. 10, a polynucleotide encoding the same and a vector comprising the polynucleotide, a host cell transformed with the vector, a method for producing the human serum albumin-TIMP2 fusion protein and a pharmaceutical composition comprising the human serum albumin-TIMP2 fusion protein. The human serum albumin-TIMP2 fusion protein is stable and retains the activity of TIMP2, thus it can be used as a pharmaceutical composition to treat diseases related to angiogenesis and/or metastasis of cancer cells.
REFERENCES:
patent: 5595885 (1997-01-01), Stetler-Stevenson et al.
patent: 5643752 (1997-07-01), Hawkins et al.
patent: 5876969 (1999-03-01), Fleer et al.
Wingfield et al., “Biophysical and Functional Characterization of Full-length, Recombinant Human Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) Produced inEscherichia coli”, The Journal of Biological Chemistry 1999, 274(30): 21362-21368.
Hajitou et al., “Down-Regulation of Vascular Endothelial Growth Factor by Tissue Inhibitor of Metalloproteinase-2: Effect on in Vivo Mammary Tumor”, Cancer Research 2001, 61: 3450-3457.
Fernandez et al., “Structural and Functional Uncoupling of the Enzymatic and Angiogenic Inhibitory Activities of Tissue Inhibitor of Metalloproteinase-2 (TIMP-2)”, The Journal of Biological Chemistry 2003, 278(42): 40989-40995.
Feldman et al., “Modulation of Tumor-host Interactions, Angiogenesis, and Tumor Growth by Tissue Inhibitor of Metalloproteinase 2 via a Novel Mechanism”, Cancer Research 2004, 64: 4481-4486.
Rajan et al., “Presence of an N-Terminal Polyhistidine Tag Facilitates Stable Expression of an Otherwise Unstable N-Terminal Domain of Mouse Tissue Inhibitor of Metalloproteinase-1 inEscherichia coli”, Pprotein Expression and Purification 1998, 13: 67-72.
Nomura et al., “Secretion bySaccharomyces cerevisiaeof human apolipoprotein E as a fusion to serum albumin.”, Biosci Biotechnol Biochem. Mar. 1995, 59(3): 532-4.
Cockett et al., “High level expression of tissue inhibitor of metalloproteinases in Chinese hamster ovary cells using glutamine synthetase gene amplification.”, Biotechnology Jul. 1990, 8(7): 662-7.
Chang Jae-Young
Kang Hyun Ah
Kim Jeong-Yoon
Kim Min-Young
Park Eun-Kyu
Angiolab, Inc.
JHK Law
Kim Joseph Hyosuk
Leadbio, Inc.
Wax Robert A.
LandOfFree
Human serum albumin-TIMP2 fusion protein, a polynucleotide... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human serum albumin-TIMP2 fusion protein, a polynucleotide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human serum albumin-TIMP2 fusion protein, a polynucleotide... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3742848